1 – 49 of 49
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
MRI morphological characteristics of lymph nodes in anal squamous cell carcinoma
2024) In Abdominal Radiology(
- Contribution to journal › Article
- 2023
-
Mark
Nordic anal cancer (NOAC) group consensus guidelines for risk-adapted delineation of the elective clinical target volume in anal cancer
(
- Contribution to journal › Article
- 2022
-
Mark
A Machine-Learning-Based Bibliometric Analysis of the Scientific Literature on Anal Cancer
(
- Contribution to journal › Article
- 2021
-
Mark
Patterns of pathologic lymph nodes in anal cancer : a PET-CT-based analysis with implications for radiotherapy treatment volumes
(
- Contribution to journal › Article
-
Mark
Sarcopenia and dosimetric parameters in relation to treatment-related leukopenia and survival in anal cancer
(
- Contribution to journal › Article
- 2020
-
Mark
Palliative short-course hypofractionated radiotherapy followed by chemotherapy in esophageal adenocarcinoma : the phase II PALAESTRA trial
(
- Contribution to journal › Article
-
Mark
Treatment-related leukopenia in anal cancer patients associated with worse outcome : results of a retrospective cohort study
(
- Contribution to journal › Letter
-
Mark
Patterns of recurrence in anal cancer : A detailed analysis
(
- Contribution to journal › Article
-
Mark
Evaluation of the stage classification of anal cancer by the TNM 8th version versus the TNM 7th version
(
- Contribution to journal › Article
- 2019
-
Mark
Physical activity and survival following breast cancer
(
- Contribution to journal › Article
- 2018
-
Mark
Primary surgery with or without postoperative radiotherapy in early stage squamous cell carcinoma in the anal canal and anal margin
(
- Contribution to journal › Article
-
Mark
Determinants for local tumour control probability after radiotherapy of anal cancer
(
- Contribution to journal › Article
-
Mark
Podocalyxin-like protein as a predictive biomarker for benefit of neoadjuvant chemotherapy in resectable gastric and esophageal adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Protein array profiling of circulating angiogenesis-related factors during bevacizumab containing treatment in metastatic colorectal cancer
(
- Contribution to journal › Article
- 2017
-
Mark
Swelling and mass transport properties of nanocellulose-HPMC composite films
(
- Contribution to journal › Article
-
Mark
Occupational sedentariness and breast cancer risk
(
- Contribution to journal › Article
-
Mark
Vasoactive peptides associate with treatment outcome ofbevacizumab-containing therapy in metastatic colorectal cancer
(
- Contribution to journal › Article
- 2016
-
Mark
Expression of IFITM1 as a prognostic biomarker in resected gastric and esophageal adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Expression of podocalyxin-like protein is an independent prognostic biomarker in resected esophageal and gastric adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Drug costs and benefits of medical treatments in high-unmet need solid tumours in the Nordic countries
(
- Contribution to journal › Article
-
Mark
A randomized study of KRAS-guided maintenance therapy with bevacizumab, erlotinib or metronomic capecitabine after first line induction treatment of metastatic colorectal cancer: the Nordic ACT2 trial
(
- Contribution to journal › Article
- 2015
-
Mark
Phase I study of cetuximab in combination with 5-fluorouracil, mitomycin C and radiotherapy in patients with locally advanced anal cancer.
(
- Contribution to journal › Article
- 2014
-
Mark
Anal carcinoma - Survival and recurrence in a large cohort of patients treated according to Nordic guidelines.
(
- Contribution to journal › Article
-
Mark
Epidermal Growth Factor-like Domain 7 Predicts Response to First-Line Chemotherapy and Bevacizumab in Patients with Metastatic Colorectal Cancer.
(
- Contribution to journal › Article
- 2013
-
Mark
Physical activity during and after adjuvant chemotherapy in patients with breast cancer.
(
- Contribution to journal › Article
-
Mark
MicroRNA-126 and epidermal growth factor-like domain 7-an angiogenic couple of importance in metastatic colorectal cancer. Results from the Nordic ACT trial
(
- Contribution to journal › Article
-
Mark
A randomized phase III trial on maintenance treatment with bevacizumab alone or in combination with erlotinib after chemotherapy and bevacizumab in metastatic colorectal cancer: the Nordic ACT Trial.
(
- Contribution to journal › Article
- 2012
-
Mark
Using intravital microscopy to observe bevacizumab-mediated anti-angiogenesis in human head and neck squamous cell carcinoma xenografts
(
- Contribution to journal › Article
-
Mark
The predictive value of single nucleotide polymorphisms in the VEGF system to the efficacy of first-line treatment with bevacizumab plus chemotherapy in patients with metastatic colorectal cancer Results from the Nordic ACT trial
(
- Contribution to journal › Article
-
Mark
Autocrine epidermal growth factor receptor ligand production and cetuximab response in head and neck squamous cell carcinoma cell lines.
(
- Contribution to journal › Article
-
Mark
Cetuximab sensitivity associated with oxaliplatin resistance in colorectal cancer.
(
- Contribution to journal › Article
-
Mark
Phase III Trial of Cetuximab With Continuous or Intermittent Fluorouracil, Leucovorin, and Oxaliplatin (Nordic FLOX) Versus FLOX Alone in First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-VII Study.
(
- Contribution to journal › Article
- 2011
-
Mark
Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer.
(
- Contribution to journal › Article
- 2010
-
Mark
Randomized phase II study of sequential docetaxel and irinotecan with 5-fluorouracil/folinic acid (leucovorin) in patients with advanced gastric cancer: the GATAC trial
(
- Contribution to journal › Article
-
Mark
Multicentre phase I-II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable pancreatic and biliary tract cancer: The CORGI-U study
(
- Contribution to journal › Article
-
Mark
Reduced drug accumulation is more important in acquired resistance against oxaliplatin than against cisplatin in isogenic colon cancer cells.
(
- Contribution to journal › Article
- 2009
-
Mark
Epidermal growth factor receptor status and persistent activation of Akt and p44/42 MAPK pathways correlate with the effect of cetuximab in head and neck and colon cancer cell lines.
(
- Contribution to journal › Article
-
Mark
The effect on the small bowel of 5-FU and oxaliplatin in combination with radiation using a microcolony survival assay.
(
- Contribution to journal › Article
-
Mark
Multicentre phase II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable colorectal cancer: The CORGI-L study.
(
- Contribution to journal › Article
- 2008
-
Mark
Efficacy of preoperative radiochemotherapy in patients with locally advanced pancreatic carcinoma
(
- Contribution to journal › Article
-
Mark
How does light affect melatonin?
(
- Contribution to journal › Letter
- 2007
-
Mark
Proteomic analysis identifies candidate proteins associated with distant recurrences in breast cancer after adjuvant chemotherapy.
(
- Contribution to journal › Article
-
Mark
Dose-volume relationships between enteritis and irradiated bowel volumes during 5-fluorouracil and oxaliplatin based chemoradiotherapy in locally advanced rectal cancer
(
- Contribution to journal › Article
- 2006
-
Mark
Gene expression profilers and conventional clinical markers to predict distant recurrences for premenopausal breast cancer patients after adjuvant chemotherapy.
(
- Contribution to journal › Article
-
Mark
Comparative renal, hepatic, and bone marrow toxicity of Cisplatin and radioactive Cisplatin ((191)pt) in wistar rats.
(
- Contribution to journal › Article
- 2005
-
Mark
Gene expression profiling in chemoresistant variants of three cell lines of different origin.
(
- Contribution to journal › Article
-
Mark
In vitro radiosensitization by oxaliplatin and 5-fluorouracil in a human colon cancer cell line.
(
- Contribution to journal › Article
- 2001
-
Mark
Antitumor effect of radioactive cisplatin (191Pt) on nude mice
(
- Contribution to journal › Article
- 1996
-
Mark
Pharmacokinetic and pharmacodynamic studies on cisplatin in mice and men
1996)(
- Thesis › Doctoral thesis (compilation)